Why Perion Network Stock Crumbled This Week
On the afternoon of Perion's earnings release, Lake Street Capital Markets pundit Eric Martinuzzi cut his price target on the ...
Why Exelixis Stock Trounced the Market on Thursday
Cancer drug specialist Exelixis ( EXEL 5.02%) was quite the stock market star on Friday. Following news that it's making a big, shareholder-pleasing move, market players piled into the company to push ...